primary myelofibrosis

Showing 76 - 99 of 99

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Burkitt Lymphoma Trial in Winston-Salem (cefepime HCl)

Completed
  • Adult Acute Lymphoblastic Leukemia
  • +38 more
  • cefepime hydrochloride
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 16, 2018

Anemia, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale, New York (ruxolitinib phosphate, danazol,

Completed
  • Anemia
  • +2 more
  • ruxolitinib phosphate
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Sep 15, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +178 more
  • fludarabine phosphate
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017

Myelofibrosis, Polycythemia Vera, Primary Myelofibrosis Trial (procedure, other, biological)

Withdrawn
  • Myelofibrosis
  • +3 more
  • Bone Marrow Aspiration and Biopsy
  • +2 more
  • (no location specified)
Oct 21, 2016

Acute Myeloid Leukemia in Remission, Primary Myelofibrosis, Primary Myelofibrosis, Prefibrotic Stage Trial in Duarte (procedure,

Withdrawn
  • Acute Myeloid Leukemia in Remission
  • +4 more
  • Allogeneic Bone Marrow Transplantation
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Sep 12, 2016

Primary Myelofibrosis Trial in Leipzig, Firenze, Madrid (Ruxolitinib)

Terminated
  • Primary Myelofibrosis
  • Leipzig, Germany
  • +2 more
Feb 24, 2016

Reversible Secondary Myelofibrosis or Clonal Myeloproliferative

Terminated
  • Primary Myelofibrosis
  • +3 more
    • Salt Lake City, Utah
    • +1 more
    Mar 17, 2016

    Primary Myelofibrosis, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Post-Essential Thrombocythemia Related

    Unknown status
    • Primary Myelofibrosis
    • +2 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Mar 5, 2015

    Accelerated Phase Chronic Myelogenous Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +9 more
    • fludarabine phosphate
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University/Sidney Kimmel Cancer Center
    Dec 16, 2014

    Myelofibrosis, Primary Myelofibrosis, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Trial in New York (mAb to

    Terminated
    • Myelofibrosis
    • +3 more
    • monoclonal antibody to TGF-beta
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Nov 21, 2014

    Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Boston (lenalidomide, prednisone, laboratory

    Completed
    • Essential Thrombocythemia
    • +2 more
    • Boston, Massachusetts
      Eastern Cooperative Oncology Group
    May 2, 2014

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +88 more
    • palifermin
    • +3 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Feb 19, 2014

    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +84 more
    • sunitinib malate
    • +2 more
    • Los Angeles, California
    • +10 more
    Mar 14, 2014

    Chronic Myelomonocytic Leukemia, Essential Thrombocythemia, Polycythemia Vera Trial in Chicago (imatinib mesylate, laboratory

    Completed
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • imatinib mesylate
    • laboratory biomarker analysis
    • Chicago, Illinois
      University of Chicago
    Feb 24, 2014

    Primary Myelofibrosis Trial in Rochester (thalidomide, laboratory biomarker analysis)

    Completed
    • Primary Myelofibrosis
    • Rochester, Minnesota
      North Central Cancer Treatment Group
    Oct 7, 2013

    Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Rochester (tipifarnib, laboratory biomarker

    Completed
    • Essential Thrombocythemia
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Jun 3, 2013

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia Trial in

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +33 more
    • Baltimore, Maryland
    • +1 more
    May 1, 2013

    Myeloproliferative Neoplasms: an In-depth Case-control Study

    Unknown status
    • Polycythemia Vera
    • +2 more
    • Methodological pens
    • +2 more
    • Southampton, England, United Kingdom
    • +2 more
    Apr 23, 2013

    Myeloproliferative Neoplasms and Bone Structure

    Unknown status
    • Polycythemia Vera
    • +2 more
      • Odense, Region Syddanmark, Denmark
        Faculty of Health Sciences, Institute of Clinical Research
      Mar 20, 2013

      Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, AIDS-related Peripheral/Systemic Lymphoma Trial

      Completed
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +80 more
      • imatinib mesylate
      • pharmacological study
      • Pittsburgh, Pennsylvania
        University of Pittsburgh
      Feb 6, 2013

      Primary Myelofibrosis, Fibrosis, Bone Marrow Trial in Scottsdale, Palo Alto, Houston (IPI-926)

      Completed
      • Primary Myelofibrosis
      • Fibrosis, Bone Marrow
      • Scottsdale, Arizona
      • +2 more
      Nov 14, 2012

      Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

      Withdrawn
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +102 more
      • management of therapy complications
      • musculoskeletal complications management/prevention
      • (no location specified)
      Jul 5, 2012

      Labile Plasma Iron in Myelodysplastic Syndromes and Primary

      Unknown status
      • Myelodysplastic Syndrome
      • Primary Myelofibrosis
        • Holon,, Israel
          Wolfson Medical Center
        Apr 7, 2011